Carter Jason S
Chief Legal Officer
Carter Jason S has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 25, 2025.
On the most recent filing, Carter Jason S is listed as Chief Legal Officer at Vera Therapeutics, Inc. Inside the rolling window, Carter Jason S reported no open-market purchases and 1 open-market sale totaling $107K in VERA.
Companies traded
Other insiders at VERA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$107K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Carter Jason S made?
Carter Jason S has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Carter Jason S trade?
Carter Jason S has filed SEC Form 4 disclosures for 1 company, including VERA.
When was Carter Jason S's most recent SEC Form 4 filing?
Carter Jason S's most recent SEC Form 4 filing on Tracefour is dated Nov 25, 2025.
What is Carter Jason S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Carter Jason S is listed as Chief Legal Officer.
What is Carter Jason S's total buy and sell value in the current window?
Inside the rolling retention window, Carter Jason S bought $0 and sold $107K based on SEC Form 4 filings.
What was Carter Jason S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,864 VERA shares on 2025-11-21, worth $107K, per SEC Form 4 filings.